Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMD1JVZ)

Drug Name

ISIS 19213 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting CD40 messenger RNA (CD40 mRNA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
NJA-730	DM4I02O	Graft-versus-host disease	4B24	Phase 1	[2]
ISIS 19211	DMKFCD5	Discovery agent	N.A.	Investigative	[1]
ISIS 19220	DMIKEXD	Discovery agent	N.A.	Investigative	[1]
ISIS 19219	DMFAWGX	Discovery agent	N.A.	Investigative	[1]
ISIS 19221	DMKOFNX	Discovery agent	N.A.	Investigative	[1]
ISIS 19218	DMX4I5A	Discovery agent	N.A.	Investigative	[1]
ISIS 19217	DMQK0AL	Discovery agent	N.A.	Investigative	[1]
ISIS 19212	DMLQT5F	Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	US patent application no. 6,197,584, Antisense modulation of CD40 expression.
2	Clinical pipeline report, company report or official report of NapaJen Pharma.